America has announced to impose heavy tariffs on imported generic medicines from August 2028. According to US President Donald Trump, the purpose of this step is to increase the production of pharmaceutical medicines in America. This announcement by Trump is likely to have a serious impact on India, because it is the largest exporter of generic medicines of America.

Trump said in a post on his social media platform Truth Social that this tariff plan will be implemented in several phases and it will start from August 1. America will not impose any tariff on all generic medicines coming into the country for the first two years. He said that the tariff will be increased to 100% in the third year and after that it will become 200%.

Trump wrote, “Starting August 1, 2026, the tariff on all generic drugs coming to America will be zero for two years. After this, the tariff will be increased to 100 percent for one year and then to 200 percent after that.” He further said, “This is being done to bring the production of generic medicines back to America. Companies that do not build plants and equipment within the stipulated time frame will be fined.”

What is Trump’s motive?
The US President said that the purpose of this policy is to protect the people of America. He said, “The policy related to patented, branded or innovative medicines, which has been very successful, will remain the same.” Let us tell you that India is called the pharmacy of the world because it supplies generic medicines to countries all over the world.

Medicines worth billions of dollars are sent to America
The share of Indian generic medicines in America is about 40 percent. According to a report by the Global Trade Research Initiative, India exported medicines worth US $ 9.7 billion to the US in the financial year 2024-2025, which was 38 percent of its total global drug exports of US $ 25.8 billion. However, it is not yet clear what impact Trump’s new tariff threats will have on Indian pharmaceutical companies. India and the US had signed a trade agreement in February, in which it was decided that India would get negotiated results regarding generic medicines.

read this also

America’s stockpile of missiles emptied while fighting the war with Iran? Who made this shocking claim in US?

US President Donald Trump has affected the economies of many countries through the tariff bomb. Its effect has been seen in India also. However, at the moment there is a relief news that the Trump administration has postponed the plan to impose tariffs on generic medicines. This decision has brought great relief to the Indian pharmaceutical industry, because most of the cheap medicines used in America are exported from India. If tariffs were imposed, Indian medicines would become expensive in the American market and their demand could decrease.

According to the report of medical data analytics company IQVIA, about 47% of generic medicines used in America come from India. India’s share is so large that it is often called the Pharmacy of the World. Indian medicines have an important contribution in the health sector of America. Life-saving medicines like diabetes, blood pressure, cholesterol and antibiotics are imported in large quantities from Indian companies. The price of these medicines is much lower than local production in America, which provides relief to the citizens there.

Why was this U-turn taken?

According to The Wall Street Journal report, the Trump administration had started an investigation into imposing tariffs on generic drugs. In this investigation, not only the finished medicines but also the raw materials (API) used in their manufacturing were included. However, after investigation, the Commerce Department recommended limiting this scope, because many experts believed that imposing tariffs on generic drugs would increase drug prices in the US and could also lead to market shortages. One group wanted to bring production back to America by imposing high tariffs on drugs from foreign countries, while the other group believed that such a step would be harmful to the American people.

Tariff war and global impact

Donald Trump’s tariff policy has made headlines globally in the last few months. First they imposed import duties on China, in response to which China stopped purchasing American agricultural products. This caused a big blow to American farmers and created a crisis situation in the agricultural market there. Similarly, if drug tariffs were imposed on India, it would have an impact on the American health system as well. Without India’s affordable and reliable medicines, the same treatment would have cost much more to American patients.

Role of Indian Pharma Industry

India’s pharmaceutical industry is the leader in the field of generic medicines worldwide. Indian companies send cheap and high quality medicines not only to America but also to countries in Europe, Africa and Asia. The US market is the largest export destination for India, where billions of dollars worth of medicines are sent every year, so postponing the Trump administration’s decision is a relief news for Indian companies.

Also read: Operation Sindoor: ‘Stay fit and ready, anytime…’, Asim Munir again spews venom against India, why did he give this instruction to the army?